Evidence map›Paper›PMID 41579162›Full record

ArticleDiabetologia2026

Type 1 diabetes screening: reframing the debate from paternalism to partnership. Reply to Scaramuzza AE, Iafusco D, Cherubini V [letter] Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure. Reply to Mallone R, Bandini A [letter].

Stephen E Gitelman, Kimber Simmons, Jennifer L Sherr, Teresa Quattrin, William E Russell, Bhuvana Sunil, Steven M Willi, Laura A Knecht, Elisabeth Niemoeller, Idlir Licaj and 2 more

Abstract readLetter
In one paragraph

Article in Diabetologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Stephen E GitelmanDepartment of Pediatrics, University of California at San Francisco, San Francisco, CA, USA. Stephen.Gitelman@ucsf.edu.ORCID http://orcid.org/0000-0003-4186-4107
Kimber SimmonsBarbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora, CO, USA.ORCID http://orcid.org/0000-0003-0560-5773
Jennifer L SherrDepartment of Pediatrics, Pediatric Endocrinology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-9301-3043
Teresa QuattrinDepartment of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.ORCID http://orcid.org/0000-0002-2385-9278
William E RussellDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-7609-0434
Bhuvana SunilMary Bridge Children's Hospital, Tacoma, WA, USA.
Steven M WilliDivision of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-4910-2425
Laura A KnechtSanofi, Morristown, NJ, USA.
Elisabeth NiemoellerSanofi, Frankfurt, Germany.
Idlir LicajSanofi, Paris, France.ORCID http://orcid.org/0000-0003-3389-0735
Diana MillerSanofi, Morristown, NJ, USA.
Linda A DiMeglioDivision of Pediatric Endocrinology and Diabetology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0002-8033-6078

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetic ketoacidosisDisease-modifying therapyPresymptomaticScreeningType 1 diabetes

Identifiers

PMID41579162
PMCPMC12957048

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.